AK

Amrendra Kumar

Active Director Director DIN 10132872
DIN 10132872 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Amrendra Kumar

Data last updated:

Amrendra Kumar is a Director at Beatriz Bio Remedies Private Limited (since 2023). Beatriz Bio Remedies Private Limited reported revenue of ₹30 Lakh (FY 2025).

DIN 10132872
Primary Designation Director
First Appointment 25 Apr 2023
Oldest Company Age 3 yrs
Largest company Beatriz Bio Remedies Private Limited · ₹30 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beatriz Bio Remedies Private Limited U46497BR2023PTC062774
Director25 Apr 20232023₹30 Lakh (FY 2025)Active

Board colleagues of Amrendra Kumar

NameDINCompanyDesignation
Nikhil Kumar10132871Beatriz Bio Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Beatriz Bio Remedies Private Limited
Premium access

Shareholding and investment profile for Amrendra Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amrendra Kumar

Amrendra Kumar currently holds 1 directorship: Beatriz Bio Remedies Private Limited (Director, since 25 Apr 2023, revenue ₹30 Lakh (FY 2025)).

Amrendra Kumar was first appointed on 25 Apr 2023 as Director at Beatriz Bio Remedies Private Limited.

The current boards of Amrendra Kumar's companies include Nikhil Kumar (Beatriz Bio Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available